Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis-Reference-Cited by-同舟云学术

Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis

Published:2012-11-30 Issue:11 Volume:7 Page:e47578
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Börnsen Lars,Christensen Jeppe Romme,Ratzer Rikke,Oturai Annette Bang,Sørensen Per Soelberg,Søndergaard Helle Bach,Sellebjerg Finn

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference41 articles.

1. Natalizumab effects on immune cell responses in multiple sclerosis.;M Niino;Ann Neurol,2006

2. Role of the VLA-4 molecule in T cell costimulation. Identification of the tyrosine phosphorylation pattern induced by the ligation of VLA-4;T Sato;J Immunol,1995

3. Pharmacological properties, toxicology and scientific rationale for the use of natalizumab (Tysabri) in inflammatory diseases.;O Stuve;CNS Drug Rev,2007

4. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.;CH Polman;N Engl J Med,2006

5. Novel mechanisms of immune modulation of natalizumab in multiple sclerosis patients.;M Skarica;J Neuroimmunol,2011

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study;Neurotherapeutics;2024-07

2. Effect of siponimod on lymphocyte subsets in active secondary progressive multiple sclerosis and clinical implications;Journal of Neurology;2024-04-17

3. OX40 (CD134) Expression on T Regulatory Cells Is Related to Serious Hypertensive Disorders in Pregnancy;Journal of Cardiovascular Development and Disease;2023-10-17

4. Comparison of OX40 expression in patients with multiple sclerosis and neuromyelitis optica as an approach to diagnosis;Allergy, Asthma & Clinical Immunology;2023-03-10

5. T Lymphocyte Serotonin 5-HT7 Receptor Is Dysregulated in Natalizumab-Treated Multiple Sclerosis Patients;Biomedicines;2022-09-27